Clinical Trials Directory

Trials / Completed

CompletedNCT00707499

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158

A Single-Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of BMS 747158 in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Lantheus Medical Imaging · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical research study is to learn the safety and biodistribution of BMS747158 in normal, healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGBMS747158Single dose administration.

Timeline

Start date
2007-09-01
Primary completion
2008-05-01
Completion
2008-06-01
First posted
2008-07-01
Last updated
2020-11-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00707499. Inclusion in this directory is not an endorsement.

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158 (NCT00707499) · Clinical Trials Directory